Skip to main content
Top
Published in: Archives of Dermatological Research 8/2008

01-09-2008 | Original Paper

Increased frequency of pulmonary hypertension in psoriasis patients

Authors: Yilmaz Gunes, Mustafa Tuncer, Omer Calka, Unal Guntekin, Necmettin Akdeniz, Hakki Simsek, Ilknur Yorgun Ozdemir

Published in: Archives of Dermatological Research | Issue 8/2008

Login to get access

Abstract

Several reports have demonstrated an association between psoriasis and cardiovascular diseases such as hypertension, valvular disease and arrhythmia. However, the data is scarce. Forty-seven psoriasis patients and 20 healthy people underwent transthoracic echocardiographic examination including pulse- and tissue Doppler analysis and 24-h ambulatory electrocardiographic monitoring including heart rate variability (HRV) analysis. Patients having systemic hypertension, diabetes mellitus, history of structural or ischemic heart disease, chronic obstructive pulmonary disease and any associated systemic disease were excluded. Psoriasis Area and Severity Index (PASI) was calculated and severe psoriasis was defined in the case of history of hospitalizations for psoriasis and/or getting systemic therapy. Mean age of the patients was 35.7 ± 12.9 years and disease duration was 123.2 ± 84.3 (3–360) months. PASI ranged from 0.4 to 34.0 (mean ± SD: 7.1 ± 6.6) and 20 (42.6%) patients had severe psoriasis. There were no significant differences between psoriasis patients and control group with respect to mean values of blood pressure, body mass index, lipid profile and cardiac dimensions. However, frequency of being overweight was significantly higher in psoriasis patients (42.6 vs. 10.0%, P = 0.011). No patient had valvular disease. Mild pulmonary hypertension (PH) (30–40 mmHg) was significantly more frequent in psoriasis patients (31.9 vs. 0%, P = 0.003). Pulse wave mitral Doppler deceleration and isovolumetric relaxation times were significantly longer in psoriasis patients (195.9 ± 29.7 vs. 191.6 ± 14.7 ms, P = 0.002 and 91.6 ± 14.7 vs. 79.6 ± 10.5 ms, P = 0.001, respectively). However, frequency of diastolic dysfunction was not significantly different than the control group (8.5 vs. 0%, P = 0.309). HRV parameters and frequency of supraventricular and ventricular premature beats were not significantly different between the groups. No patient had ventricular tachycardia. Echocardiographic follow-up of psoriasis patients may be important due to possible association of PH. However, incidences of structural heart disease and arrythmia are not increased in psoriasis according to our results.
Literature
1.
go back to reference Biyik I, Narin A, Bozok MA, Ergene O (2006) Echocardiographic and clinical abnormalities in patients with psoriasis. J Int Med Res 34:632–639PubMed Biyik I, Narin A, Bozok MA, Ergene O (2006) Echocardiographic and clinical abnormalities in patients with psoriasis. J Int Med Res 34:632–639PubMed
2.
go back to reference Carvalho M, Soares R, Ribeiro F, Gaião L, Rosa M, Rodrigues M, Silva J, Queiroz MV, Carrageta M (1990) Rhythm profile in patients with psoriatic arthritis. Rev Port Cardiol 9:311–317PubMed Carvalho M, Soares R, Ribeiro F, Gaião L, Rosa M, Rodrigues M, Silva J, Queiroz MV, Carrageta M (1990) Rhythm profile in patients with psoriatic arthritis. Rev Port Cardiol 9:311–317PubMed
4.
go back to reference Cristofaro P, Opal SM (2006) Role of Toll-like receptors in infection and immunity: clinical implications. Drugs 66:15–29PubMedCrossRef Cristofaro P, Opal SM (2006) Role of Toll-like receptors in infection and immunity: clinical implications. Drugs 66:15–29PubMedCrossRef
5.
go back to reference Dawson JK, Goodson NG, Graham DR, Lynch MP (2000) Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients. Rheumatology 39:1320–1325PubMedCrossRef Dawson JK, Goodson NG, Graham DR, Lynch MP (2000) Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients. Rheumatology 39:1320–1325PubMedCrossRef
6.
go back to reference Dorfmüller P, Perros F, Balabanian K, Humbert M (2003) Inflammation in pulmonary arterial hypertension. Eur Respir J 22:358–363PubMedCrossRef Dorfmüller P, Perros F, Balabanian K, Humbert M (2003) Inflammation in pulmonary arterial hypertension. Eur Respir J 22:358–363PubMedCrossRef
7.
go back to reference Fredriksson T, Pettersson U (1978) Severe psoriasis-oral therapy with a new retinoid. Dermatologica 157:238–244PubMed Fredriksson T, Pettersson U (1978) Severe psoriasis-oral therapy with a new retinoid. Dermatologica 157:238–244PubMed
8.
go back to reference Gaspari AA (2006) Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol 54:S67–S80PubMedCrossRef Gaspari AA (2006) Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol 54:S67–S80PubMedCrossRef
9.
go back to reference Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296:1735–1741PubMedCrossRef Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296:1735–1741PubMedCrossRef
10.
go back to reference Ghoreschi K, Thomas P, Breit S, Dugas M, Mailhammer R, van Eden W, van der Zee R, Biedermann T, Prinz J, Mack M, Mrowietz U, Christophers E, Schlöndorff D, Plewig G, Sander CA, Röcken M (2003) Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 9:40–46PubMedCrossRef Ghoreschi K, Thomas P, Breit S, Dugas M, Mailhammer R, van Eden W, van der Zee R, Biedermann T, Prinz J, Mack M, Mrowietz U, Christophers E, Schlöndorff D, Plewig G, Sander CA, Röcken M (2003) Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 9:40–46PubMedCrossRef
11.
go back to reference Gonzalez-Juanatey C, Amigo-Diaz E, Miranda-Filloy JA, Testa A, Revuelta J, Garcia-Porrua C, Martin J, Llorca J, Gonzalez-Gay MA (2006) Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerotic risk factors. Semin Arthritis Rheum 35:333–339PubMedCrossRef Gonzalez-Juanatey C, Amigo-Diaz E, Miranda-Filloy JA, Testa A, Revuelta J, Garcia-Porrua C, Martin J, Llorca J, Gonzalez-Gay MA (2006) Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerotic risk factors. Semin Arthritis Rheum 35:333–339PubMedCrossRef
12.
go back to reference Kimura H, Kasahara Y, Kurosu K, Sugito K, Takiguchi Y, Terai M, Mikata A, Natsume M, Mukaida N, Matsushima K, Kuriyama T (1998) Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Lab Invest 78:571–581PubMed Kimura H, Kasahara Y, Kurosu K, Sugito K, Takiguchi Y, Terai M, Mikata A, Natsume M, Mukaida N, Matsushima K, Kuriyama T (1998) Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Lab Invest 78:571–581PubMed
13.
go back to reference Kremers HM, McEvoy MT, Dann FJ, Gabriel SE (2007) Heart disease in psoriasis. J Am Acad Dermatol 57:347–354PubMedCrossRef Kremers HM, McEvoy MT, Dann FJ, Gabriel SE (2007) Heart disease in psoriasis. J Am Acad Dermatol 57:347–354PubMedCrossRef
14.
go back to reference Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463PubMedCrossRef Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463PubMedCrossRef
16.
go back to reference Ludwig RJ, Herzog C, Rostock A, Ochsendorf FR, Zollner TM, Thaci D, Kaufmann R, Vogl TJ, Boehncke WH (2007) Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 156:271–276PubMedCrossRef Ludwig RJ, Herzog C, Rostock A, Ochsendorf FR, Zollner TM, Thaci D, Kaufmann R, Vogl TJ, Boehncke WH (2007) Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 156:271–276PubMedCrossRef
17.
go back to reference Ludwig RJ, Schultz JE, Boehncke WH, Podda M, Tandi C, Krombach F, Baatz H, Kaufmann R, von Andrian UH, Zollner TM (2004) Activated, but not resting platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules. J Invest Dermatol 122:830–836PubMedCrossRef Ludwig RJ, Schultz JE, Boehncke WH, Podda M, Tandi C, Krombach F, Baatz H, Kaufmann R, von Andrian UH, Zollner TM (2004) Activated, but not resting platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules. J Invest Dermatol 122:830–836PubMedCrossRef
18.
go back to reference Magliano M, Isenberg DA, Hillson J (2002) Pulmonary hypertension in autoimmune rheumatic diseases. Where are we now? Arthritis Rheum 46:1997–2009PubMedCrossRef Magliano M, Isenberg DA, Hillson J (2002) Pulmonary hypertension in autoimmune rheumatic diseases. Where are we now? Arthritis Rheum 46:1997–2009PubMedCrossRef
19.
go back to reference Markuszeski L, Bissinger A, Janusz I, Narbutt J, Jedrzejowska AS, Zalewska A (2007) Heart rate and arrhythmia in patients with psoriasis vulgaris. Arch Med Res 38:64–69PubMedCrossRef Markuszeski L, Bissinger A, Janusz I, Narbutt J, Jedrzejowska AS, Zalewska A (2007) Heart rate and arrhythmia in patients with psoriasis vulgaris. Arch Med Res 38:64–69PubMedCrossRef
20.
go back to reference Marongiu F, Sorano GG, Bibbo C, Pistis MP, Conti M, Mulas P, Balestrieri A, Biggio P (1994) Abnormalities of blood coagulation and fibrinolysis in psoriasis. Dermatology 189:32–37PubMedCrossRef Marongiu F, Sorano GG, Bibbo C, Pistis MP, Conti M, Mulas P, Balestrieri A, Biggio P (1994) Abnormalities of blood coagulation and fibrinolysis in psoriasis. Dermatology 189:32–37PubMedCrossRef
21.
go back to reference Moya JL, Sanchez M, Morales MD, Brito E (1987) Mitral valve prolapse in psoriatic arthritis. Arch Intern Med 147:992PubMedCrossRef Moya JL, Sanchez M, Morales MD, Brito E (1987) Mitral valve prolapse in psoriatic arthritis. Arch Intern Med 147:992PubMedCrossRef
22.
go back to reference Muna WF, Roller DH, Craft J, Shaw RK, Ross AM (1980) Psoriatic arthritis and aortic regurgitation. JAMA 244:363–365PubMedCrossRef Muna WF, Roller DH, Craft J, Shaw RK, Ross AM (1980) Psoriatic arthritis and aortic regurgitation. JAMA 244:363–365PubMedCrossRef
23.
go back to reference Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA (1997) Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527–1533PubMedCrossRef Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA (1997) Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527–1533PubMedCrossRef
24.
go back to reference Naldi L, Chatenoud L, Linder D, Belloni Fortina A, Peserico A, Virgili AR, Bruni PL, Ingordo V, Lo Scocco G, Solaroli C, Schena D, Barba A, Di Landro A, Pezzarossa E, Arcangeli F, Gianni C, Betti R, Carli P, Farris A, Barabino GF, La Vecchia C (2005) Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case–control study. J Invest Dermatol 125:61–67PubMedCrossRef Naldi L, Chatenoud L, Linder D, Belloni Fortina A, Peserico A, Virgili AR, Bruni PL, Ingordo V, Lo Scocco G, Solaroli C, Schena D, Barba A, Di Landro A, Pezzarossa E, Arcangeli F, Gianni C, Betti R, Carli P, Farris A, Barabino GF, La Vecchia C (2005) Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case–control study. J Invest Dermatol 125:61–67PubMedCrossRef
25.
go back to reference Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH (2006) Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on obesity and heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113:898–918PubMedCrossRef Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH (2006) Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on obesity and heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113:898–918PubMedCrossRef
26.
go back to reference Saricaoglu H, Gullulu S, Bulbul Baskan E, Cordan J, Tunali S (2003) Echocardiographic findings in subjects with psoriatic arthropathy. J Eur Acad Dermatol Venereol 17:414–417PubMedCrossRef Saricaoglu H, Gullulu S, Bulbul Baskan E, Cordan J, Tunali S (2003) Echocardiographic findings in subjects with psoriatic arthropathy. J Eur Acad Dermatol Venereol 17:414–417PubMedCrossRef
27.
go back to reference Schön M, Boehncke WH (2005) Psoriasis–immunopathogenesis, genetics and therapeutic perspectives. N Engl J Med 352:1899–1912PubMedCrossRef Schön M, Boehncke WH (2005) Psoriasis–immunopathogenesis, genetics and therapeutic perspectives. N Engl J Med 352:1899–1912PubMedCrossRef
28.
go back to reference Shapiro J, Cohen AD, David M, Hodak E, Chodik G, Viner A, Kremer E, Heymann A (2007) The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case–control study. J Am Acad Dermatol 56:629–634PubMedCrossRef Shapiro J, Cohen AD, David M, Hodak E, Chodik G, Viner A, Kremer E, Heymann A (2007) The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case–control study. J Am Acad Dermatol 56:629–634PubMedCrossRef
29.
go back to reference Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M (2006) Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 298:321–328PubMedCrossRef Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M (2006) Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 298:321–328PubMedCrossRef
30.
go back to reference Wolff B, Lodziewski S, Bollmann T, Opitz CF, Ewert R (2007) Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost. Am Heart J 153:1088.e1–e7 Wolff B, Lodziewski S, Bollmann T, Opitz CF, Ewert R (2007) Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost. Am Heart J 153:1088.e1–e7
Metadata
Title
Increased frequency of pulmonary hypertension in psoriasis patients
Authors
Yilmaz Gunes
Mustafa Tuncer
Omer Calka
Unal Guntekin
Necmettin Akdeniz
Hakki Simsek
Ilknur Yorgun Ozdemir
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Archives of Dermatological Research / Issue 8/2008
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-008-0859-9

Other articles of this Issue 8/2008

Archives of Dermatological Research 8/2008 Go to the issue